Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (326)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Galeterone	CYP17 / Androgen Synthesis Inhibitor	Solid Tumour (Prostate)
Molecule Galeterone Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism CYP17 / Androgen Synthesis Inhibitor
Abiraterone Acetate	CYP17 / Androgen Synthesis Inhibitor	Solid Tumour (Prostate)
Molecule Abiraterone Acetate Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism CYP17 / Androgen Synthesis Inhibitor
Trastuzumab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Emtansine (T-DM1)	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Emtansine (T-DM1) Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Deruxtecan	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Deruxtecan Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Pertuzumab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Pertuzumab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Margetuximab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Margetuximab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Zanidatamab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Zanidatamab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Disitamab Vedotin	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Disitamab Vedotin Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Duocarmazine	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Duocarmazine Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Bevacizumab	Anti-VEGF / VEGFR Agent	Solid Tumour
Molecule Bevacizumab Therapeutic Category Targeted Therapy (Antibody) Oncology Type Solid Tumour Drug Class / Mechanism Anti-VEGF / VEGFR Agent
Ramucirumab	Anti-VEGF / VEGFR Agent	Solid Tumour
Molecule Ramucirumab Therapeutic Category Targeted Therapy (Antibody) Oncology Type Solid Tumour Drug Class / Mechanism Anti-VEGF / VEGFR Agent

Galeterone Hormonal Therapy
Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism CYP17 / Androgen Synthesis Inhibitor
Abiraterone Acetate Hormonal Therapy
Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism CYP17 / Androgen Synthesis Inhibitor
Trastuzumab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Emtansine (T-DM1) Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Deruxtecan Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Pertuzumab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Margetuximab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Zanidatamab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Disitamab Vedotin Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Duocarmazine Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Bevacizumab Targeted Therapy (Antibody)
Therapeutic Category Targeted Therapy (Antibody) Oncology Type Solid Tumour Drug Class / Mechanism Anti-VEGF / VEGFR Agent
Ramucirumab Targeted Therapy (Antibody)
Therapeutic Category Targeted Therapy (Antibody) Oncology Type Solid Tumour Drug Class / Mechanism Anti-VEGF / VEGFR Agent

‹ 1 … 11 12 13 14 15 … 28 ›

Product Range

Company

Global Network

Products

Galeterone

Abiraterone Acetate

Trastuzumab

Trastuzumab Emtansine (T-DM1)

Trastuzumab Deruxtecan

Pertuzumab

Margetuximab

Zanidatamab

Disitamab Vedotin

Trastuzumab Duocarmazine

Bevacizumab

Ramucirumab

Galeterone

Abiraterone Acetate

Trastuzumab

Trastuzumab Emtansine (T-DM1)

Trastuzumab Deruxtecan

Pertuzumab

Margetuximab

Zanidatamab

Disitamab Vedotin

Trastuzumab Duocarmazine

Bevacizumab

Ramucirumab